CHICAGO (AP) — Drugs are scoring big wins against common cancers, setting new standards for how to treat many prostate, breast and lung tumors. There's even a "uni-drug" that may fight many forms of the disease.

What's striking: The drugs are beneficial in some cases for more than a year, much longer than the few months many new drugs provide. Here are highlights from the world's largest cancer meeting, the American Society of Clinical Oncology conference in Chicago.

PROSTATE CANCER

Janssen Biotech's Zytiga improved survival and delayed cancer growth for 18 months when added to standard care i...